Slowdown hits domestic pharma, market shrinks 1.8 per cent in September

The economic slowdown has hit the Rs 72,000- crore domestic pharma business, usually considered recession-proof.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news